Verily Partners With CU Anschutz and UCHealth to Advance AI-Driven Precision Medicine
Verily Life Sciences has launched a transformative partnership with CU Anschutz and UCHealth to build an AI-powered biomedical research platform. The collaboration will leverage Verily Workbench to analyze multimodal datasets across oncology, musculoskeletal, and transplant medicine. This initiative aims to accelerate drug discovery and improve clinical trial efficiency through advanced computational analytics.
Verily Life Sciences, the precision medicine subsidiary of Alphabet, has announced a groundbreaking partnership with the University of Colorado Anschutz Medical Campus and UCHealth to establish an AI-enabled biomedical research ecosystem. This collaboration represents one of the most significant precision health initiatives in recent years, combining Verily’s technological expertise with CU Anschutz’s extensive research datasets and UCHealth’s clinical capabilities.